Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98


Forward genetic approaches for elucidation of novel regulators of Lyme arthritis severity.

Bramwell KK, Teuscher C, Weis JJ.

Front Cell Infect Microbiol. 2014 Jun 5;4:76. doi: 10.3389/fcimb.2014.00076. eCollection 2014. Review.


The role of eicosanoids in experimental Lyme arthritis.

Pratt CL, Brown CR.

Front Cell Infect Microbiol. 2014 May 28;4:69. doi: 10.3389/fcimb.2014.00069. eCollection 2014. Review.


MicroRNA-146a provides feedback regulation of lyme arthritis but not carditis during infection with Borrelia burgdorferi.

Lochhead RB, Ma Y, Zachary JF, Baltimore D, Zhao JL, Weis JH, O'Connell RM, Weis JJ.

PLoS Pathog. 2014 Jun 26;10(6):e1004212. doi: 10.1371/journal.ppat.1004212. eCollection 2014 Jun.


Borrelia burgdorferi arthritis-associated locus Bbaa1 regulates Lyme arthritis and K/B×N serum transfer arthritis through intrinsic control of type I IFN production.

Ma Y, Bramwell KK, Lochhead RB, Paquette JK, Zachary JF, Weis JH, Teuscher C, Weis JJ.

J Immunol. 2014 Dec 15;193(12):6050-60. doi: 10.4049/jimmunol.1401746. Epub 2014 Nov 5.


Lysosomal β-glucuronidase regulates Lyme and rheumatoid arthritis severity.

Bramwell KK, Ma Y, Weis JH, Chen X, Zachary JF, Teuscher C, Weis JJ.

J Clin Invest. 2014 Jan;124(1):311-20. doi: 10.1172/JCI72339. Epub 2013 Dec 16.


Dual role for Fcγ receptors in host defense and disease in Borrelia burgdorferi-infected mice.

Belperron AA, Liu N, Booth CJ, Bockenstedt LK.

Front Cell Infect Microbiol. 2014 Jun 11;4:75. doi: 10.3389/fcimb.2014.00075. eCollection 2014.


Identification of quantitative trait loci governing arthritis severity and humoral responses in the murine model of Lyme disease.

Weis JJ, McCracken BA, Ma Y, Fairbairn D, Roper RJ, Morrison TB, Weis JH, Zachary JF, Doerge RW, Teuscher C.

J Immunol. 1999 Jan 15;162(2):948-56.


Significant differences between the Borrelia-infection and Borrelia-vaccination and -infection models of Lyme arthritis in C3H/HeN mice.

Nardelli DT, Luedtke JO, Munson EL, Warner TF, Callister SM, Schell RF.

FEMS Immunol Med Microbiol. 2010 Oct;60(1):78-89. doi: 10.1111/j.1574-695X.2010.00721.x.


5-Lipoxygenase-deficient mice infected with Borrelia burgdorferi develop persistent arthritis.

Blaho VA, Zhang Y, Hughes-Hanks JM, Brown CR.

J Immunol. 2011 Mar 1;186(5):3076-84. doi: 10.4049/jimmunol.1003473. Epub 2011 Jan 26.


Interval-specific congenic lines reveal quantitative trait Loci with penetrant lyme arthritis phenotypes on chromosomes 5, 11, and 12.

Ma Y, Miller JC, Crandall H, Larsen ET, Dunn DM, Weiss RB, Subramanian M, Weis JH, Zachary JF, Teuscher C, Weis JJ.

Infect Immun. 2009 Aug;77(8):3302-11. doi: 10.1128/IAI.00396-09. Epub 2009 Jun 1.


Infectious arthritis and immune dysregulation: lessons from Lyme disease.

Iliopoulou BP, Huber BT.

Curr Opin Rheumatol. 2010 Jul;22(4):451-5. doi: 10.1097/BOR.0b013e328338f73f. Review.


Follistatin-like protein 1 is a critical mediator of experimental Lyme arthritis and the humoral response to Borrelia burgdorferi infection.

Campfield BT, Nolder CL, Marinov A, Bushnell D, Davis A, Spychala C, Hirsch R, Nowalk AJ.

Microb Pathog. 2014 Aug;73:70-9. doi: 10.1016/j.micpath.2014.04.005. Epub 2014 Apr 24.


Borrelia burgdorferi aggrecanase activity: more evidence for persistent infection in Lyme disease.

Stricker RB, Johnson L.

Front Cell Infect Microbiol. 2013 Aug 14;3:40. doi: 10.3389/fcimb.2013.00040. eCollection 2013.


Bb2Bb3 regulation of murine Lyme arthritis is distinct from Ncf1 and independent of the phagocyte nicotinamide adenine dinucleotide phosphate oxidase.

Crandall H, Ma Y, Dunn DM, Sundsbak RS, Zachary JF, Olofsson P, Holmdahl R, Weis JH, Weiss RB, Teuscher C, Weis JJ.

Am J Pathol. 2005 Sep;167(3):775-85.


Gene expression profiling reveals unique pathways associated with differential severity of lyme arthritis.

Crandall H, Dunn DM, Ma Y, Wooten RM, Zachary JF, Weis JH, Weiss RB, Weis JJ.

J Immunol. 2006 Dec 1;177(11):7930-42.


Signaling through CD14 attenuates the inflammatory response to Borrelia burgdorferi, the agent of Lyme disease.

Benhnia MR, Wroblewski D, Akhtar MN, Patel RA, Lavezzi W, Gangloff SC, Goyert SM, Caimano MJ, Radolf JD, Sellati TJ.

J Immunol. 2005 Feb 1;174(3):1539-48.


Role of aggrecanase 1 in Lyme arthritis.

Behera AK, Hildebrand E, Szafranski J, Hung HH, Grodzinsky AJ, Lafyatis R, Koch AE, Kalish R, Perides G, Steere AC, Hu LT.

Arthritis Rheum. 2006 Oct;54(10):3319-29.


Interleukin-10 (IL-10) inhibits Borrelia burgdorferi-induced IL-17 production and attenuates IL-17-mediated Lyme arthritis.

Hansen ES, Medić V, Kuo J, Warner TF, Schell RF, Nardelli DT.

Infect Immun. 2013 Dec;81(12):4421-30. doi: 10.1128/IAI.01129-13. Epub 2013 Sep 16.

Supplemental Content

Support Center